MDCC Molecular Devices (MM)

Molecular Devices Announces Webcast of Presentation at UBS Global Life Sciences Conference SUNNYVALE, Calif., Sept. 21 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC), a leader in innovative solutions for drug discovery and life sciences research, today announced that Joseph D. Keegan, Ph.D., CEO and President, will present at the UBS Global Life Sciences Conference, Wednesday, September 29, 2004 at 12:00 noon (Eastern), at the Grand Hyatt New York. Molecular Devices' audio presentation will be webcast live, and can be accessed at: http://www.ibb.ubs.com/ or on the investor page at the Company's website http://www.moleculardevices.com/. The audio presentation will be archived on the Company's website for 5 days. Molecular Devices Corporation is a leading developer of high-performance, bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. Molecular Devices' systems and consumables enable pharmaceutical and biotechnology companies to leverage advances in genomics and combinatorial chemistry by facilitating the high-throughput and cost-effective identification and evaluation of drug technologies that integrate its expertise in engineering, molecular and cell biology, and chemistry. Molecular Devices enables its customers to improve research productivity and effectiveness, which ultimately accelerates the complex process of discovering and developing new drugs. DATASOURCE: Molecular Devices Corporation CONTACT: Tim Harkness of Molecular Devices Corporation, +1-408-747-3533 Web site: http://www.moleculardevices.com/

Copyright